Protease Inhibitors and Phosphatase Inhibitors
Supply Solutions Sigma Aldrich - Complete Edta-Free 3 X 20 Tablets * Third Party Item
Sigma Aldrich - Complete Edta-Free 3 X 20 Tablets * Third Party Item
Echelon Biosciences Research Labs MMP 13 Substrate, fluorogenic - 1 mg,
MMP 13 Substrate, fluorogenic - 1mg , Mca-Pro-Cha-Gly-Nva-His-Ala-Dpa-NH2 Category/Application: Enzyme Substrates This item is non returnable
Echelon Biosciences Research Labs MMP 2 Substrate, fluorogenic - 1 mg,
MMP 2 Substrate, fluorogenic - 1mg , Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 Category/Application: Enzyme Substrates This item is non returnable
Abcam JX-401, p38alpha inhibitor.
JX-401, p38alpha inhibitor.
The product is subject to the following: Abcam Restricted Use Statement
Sigma Aldrich Fine Chemicals Biosciences Plasminogen activator inhibitor 1 (PAI-1) human recombinant, expressed in E. coli, >=90% (SDS-PAGE) | 140208-23-7 | MFCD01094930 | 25UG
Plasminogen activator inhibitor 1 (PAI-1) human recombinant, expressed in E. coli, >=90% (SDS-PAGE) | Purity: >=90% (SDS-PAGE) | 140208-23-7 | MFCD01094930 | 25UG
Sigma Aldrich Fine Chemicals Biosciences D-myo-Inositol 1,3,4,5-tetrakis(phosphate) ammonium salt >=95% | MFCD00213747 | 0.1MG
D-myo-Inositol 1,3,4,5-tetrakis(phosphate) ammonium salt >=95% | Purity: >=95% | Mol Wt: 636.32 | MFCD00213747 | 0.1MG
Sigma Aldrich Fine Chemicals Biosciences Riluzole solid | 1744-22-5 | MFCD00210213 | 500MG
Riluzole solid | Mol Wt: 234.2 | 1744-22-5 | MFCD00210213 | 500MG
Abcam Ro 106-9920, NF-kappaB inhibitor, 10MG
MW 245.26 Da, Purity >95%. NF-κB inhibitor. Anti-inflammatory agent. Selectively inhibits LPS- and TNF-α-induced IκBα ubiquitination (IC₅₀ = 3 μM). Inhibits TNF-α, IL-1β and IL-6 production. Shows anti-inflammatory effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam C 7280948, PRMT1 inhibitor, 10MG
MW 276.36 Da, Purity >99%. PRMT1 inhibitor (IC₅₀ = 12.75 μM). Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam O x amflatin, HDAC inhibitor, 1MG
MW 342.4 Da, Purity >95%. Potent mammalian HDAC inhibitor (IC₅₀ = 15.7 nM). Induces an elongated cell shape morphology with filamentous protrusions. Shows antiproliferative effects. Shows antitumor effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam KD5170, HDAC inhibitor, 10MG
MW 451.6 Da, Purity >96%. Potent, non-selective HDAC inhibitor (IC₅₀ values are 14, 20, 26 and 75 nM for HDAC6, 1, 4, and 3, respectively and 2 μM for HDAC2). Antiproliferative agent. Induces oxidative stress and oxidative DNA damage. Shows antitumor effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Elastatinal, elastase inhibitor, 25MG
MW 512.6 Da, Purity >98%. Selective, irreversible elastase inhibitor. Inhibits succinyltrialanine p-nitroanilide hydrolytic enzyme (IC₅₀ = 17 μM, porcine liver). Inhibits neutrophil and microglial elastase. Shows antiviral effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Suberoyl bis-hydro x amic acid (SBHA), HDAC inhibitor, 100MG
MW 204.22 Da, Purity >98%. Potent, non-selective HDAC inhibitor (ID₅₀ values are 0.25 and 0.3 μM for HDAC1 and HDAC3 respectively). Potentiates the cytostatic effects of 5-Fluorouracil (ab142387). Induces apoptosis. Shows antiproliferative effects (IC₅₀ = 15 μM, HeLa cells).
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical Mps1tK InhIbItr 1mg
An inhibitor of Mps1/TTK (IC50 = 5.8 nM); inhibits Mps1 phosphorylation of KNL1 and increases the rate of mitosis at 100 nM; increases the number of missegregated chromosomes at 50 and 100 nM; inhibits colony formation of DLD1, HCT116, and U2OS cells (IC50s = 24.6, 20.1, and 20.6 nM, respectively)